112 related articles for article (PubMed ID: 37952361)
41. Chlamydia trachomatis infection and Vγ9Vδ2 Τ cells in women with recurrent spontaneous abortions.
Voskakis I; Tsekoura C; Keramitsoglou T; Tsantoulas E; Deligeoroglou E; Creatsas G; Varla-Leftherioti M
Am J Reprod Immunol; 2016 Nov; 76(5):358-363. PubMed ID: 27561417
[TBL] [Abstract][Full Text] [Related]
42. Screening for Chlamydia trachomatis infection in a pregnancy counseling clinic.
Binns B; Williams T; McDowell J; Brunham RC
Am J Obstet Gynecol; 1988 Nov; 159(5):1144-9. PubMed ID: 3056001
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic abortion and Chlamydia trachomatis infection.
Qvigstad E; Skaug K; Jerve F; Vik IS; Ulstrup JC
Br J Vener Dis; 1982 Jun; 58(3):182-3. PubMed ID: 6805851
[TBL] [Abstract][Full Text] [Related]
44. Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.
Gupta R; Vardhan H; Srivastava P; Salhan S; Mittal A
Reprod Biol Endocrinol; 2009 Aug; 7():84. PubMed ID: 19698128
[TBL] [Abstract][Full Text] [Related]
45. Abnormal Expression of TRAIL Receptors in Decidual Tissue of Chlamydia trachomatis-Infected Rats During Early Pregnancy Loss.
Lu J; Zhu L; Zhang L; Jiang J; Xie F; Huang Q; Li X; Yi C
Reprod Sci; 2017 Jul; 24(7):1041-1052. PubMed ID: 27852922
[TBL] [Abstract][Full Text] [Related]
46. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions.
Makhseed M; Raghupathy R; Azizieh F; Omu A; Al-Shamali E; Ashkanani L
Hum Reprod; 2001 Oct; 16(10):2219-26. PubMed ID: 11574519
[TBL] [Abstract][Full Text] [Related]
47. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy.
Blackwell AL; Thomas PD; Wareham K; Emery SJ
Lancet; 1993 Jul; 342(8865):206-10. PubMed ID: 8100930
[TBL] [Abstract][Full Text] [Related]
48. The immunomodulatory effect of intradermal allogeneic PBMC therapy in patients with recurrent spontaneous abortion.
Sarkesh A; Sorkhabi AD; Parhizkar F; Soltani-Zangbar MS; Yousefi M; Aghebati-Maleki L
J Reprod Immunol; 2023 Mar; 156():103818. PubMed ID: 36746007
[TBL] [Abstract][Full Text] [Related]
49. Sentinel surveillance of Chlamydia trachomatis infection in women terminating pregnancy.
Skjeldestad FE; Nordbø SA; Hadgu A
Genitourin Med; 1997 Feb; 73(1):29-32. PubMed ID: 9155552
[TBL] [Abstract][Full Text] [Related]
50. Screening for Chlamydia trachomatis infection in pregnant women in Martinique.
Chout RT; Vaton S; Duval-Violton D; Leguyader-Despres P; Orfila J
Sex Transm Dis; 1995; 22(4):221-7. PubMed ID: 7482104
[TBL] [Abstract][Full Text] [Related]
51. Oral Spirochete
Aravindraja C; Jeepipalli S; Vekariya KM; Botello-Escalante R; Chan EKL; Kesavalu L
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569480
[TBL] [Abstract][Full Text] [Related]
52. Underexpression of circulating miR-145-5p and miR-133a-3p are associated with breast cancer and immunohistochemical markers.
García-Magallanes N; Beltran-Ontiveros SA; Leal-León EA; Luque-Ortega F; Romero-Quintana JG; Osuna-Ramirez I; Barbosa-Jasso M; Arámbula-Meraz E
J Cancer Res Ther; 2020; 16(6):1223-1228. PubMed ID: 33342777
[TBL] [Abstract][Full Text] [Related]
53. Profiling the circulating miRNAs in mice exposed to gram-positive and gram-negative bacteria by Illumina small RNA deep sequencing.
Rau CS; Wu SC; Yang JC; Lu TH; Wu YC; Chen YC; Tzeng SL; Wu CJ; Hsieh CH
J Biomed Sci; 2015 Jan; 22(1):1. PubMed ID: 25563241
[TBL] [Abstract][Full Text] [Related]
54. MicroRNAs Modulate Pathogenesis Resulting from Chlamydial Infection in Mice.
Yeruva L; Pouncey DL; Eledge MR; Bhattacharya S; Luo C; Weatherford EW; Ojcius DM; Rank RG
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27799333
[TBL] [Abstract][Full Text] [Related]
55. Chlamydia trachomatis infection of human trophoblast alters estrogen and progesterone biosynthesis: an insight into role of infection in pregnancy sequelae.
Azenabor AA; Kennedy P; Balistreri S
Int J Med Sci; 2007 Sep; 4(4):223-31. PubMed ID: 17848980
[TBL] [Abstract][Full Text] [Related]
56. Endocervical miRNA Expression Profiles in Women Positive for Chlamydia trachomatis with Clinical Signs and/or Symptoms Are Distinct from Those in Women Positive for Chlamydia trachomatis without Signs and Symptoms.
Batteiger TA; Spencer N; Washam CL; Byrum S; Eledge M; Batteiger BE; Rank RG; Yeruva L
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32690634
[No Abstract] [Full Text] [Related]
57. Effect of treatment for Chlamydia trachomatis during pregnancy.
Rastogi S; Das B; Salhan S; Mittal A
Int J Gynaecol Obstet; 2003 Feb; 80(2):129-37. PubMed ID: 12566185
[TBL] [Abstract][Full Text] [Related]
58. Universal prophylaxis for Chlamydia trachomatis and anaerobic vaginosis in women attending for suction termination of pregnancy: an audit of short-term health gains.
Blackwell AL; Emery SJ; Thomas PD; Wareham K
Int J STD AIDS; 1999 Aug; 10(8):508-13. PubMed ID: 10471099
[TBL] [Abstract][Full Text] [Related]
59. The Predominant CD4
Jordan SJ; Gupta K; Ogendi BMO; Bakshi RK; Kapil R; Press CG; Sabbaj S; Lee JY; Geisler WM
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28100498
[No Abstract] [Full Text] [Related]
60. Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells.
Buckner LR; Lewis ME; Greene SJ; Foster TP; Quayle AJ
Cytokine; 2013 Aug; 63(2):151-65. PubMed ID: 23673287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
